VoxNeuro Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Employee Data

  • VoxNeuro has 11 Employees.(i)
  • VoxNeuro grew their employee count by -52% last year.

VoxNeuro's People

NameTitleEmail/Phone
1
Co-Founder & Chief Operating OfficerReveal Email/Phone
2
CEOReveal Email/Phone
3
Co-Founder & Advisory Board, Chair at VoxNeuro | Professor Emeritus, McMaster UniversityReveal Email/Phone
4
Chief Business OfficerReveal Email/Phone
5
VP Research And DevelopmentReveal Email/Phone
6
Brand ManagerReveal Email/Phone
7
Clinical Operations ManagerReveal Email/Phone
8
Manager NeuroscienceReveal Email/Phone
9
Clinical Success ManagerReveal Email/Phone
10
Lead Account Development RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A20632%N/AN/A
#2
$7.5M58-16%N/AN/A
#3
N/A3431%N/AN/A
#4
N/A3638%N/AN/A
#5
N/A33461%N/AN/A
#6
N/A285-3%N/AN/A
#7
N/A11592%N/AN/A
#8
N/A18747%N/AN/A
#9
N/A15544%N/AN/A
#10
N/A7828%N/AN/A
Add Company

What Is VoxNeuro?

VoxNeuro is a Software as a Medical Device (SaMD) brain health company that analyzes brain-based biomarkers to assess cognitive function. We are pushing the boundaries of brain health and empowering physicians with a breakthrough technology that delivers a comprehensive understanding of how a brain is functioning by measuring attention and concentration, information processing, and working memory. Our technology is based on thorough research, with more than 300 peer-reviewed publications on EEG, including numerous breakthrough findings, published by Chief Science Officer John F. Connolly, PhD, since 1982. VoxNeuro's research and innovation is a constant, and our technology will continue to advance the way brain health is managed. Learn more at voxneuro.com

keywords:N/A

N/A

Total Funding

11

Number of Employees

N/A

Revenue (est)

-52%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M11-58%$16.9M
#2
$2.2M110%N/A
#3
$0.7M110%$34.4M
#4
$1.4M11-45%N/A
#5
$1.4M110%N/A